Ven-A-Care, Abbott Face Off In Drug Prices Suit

Law360, New York (September 1, 2009, 5:51 PM EDT) -- Ven-A-Care of the Florida Keys Inc. and Abbott Laboratories have traded motions for partial summary judgment in a whistleblower suit filed by Ven-A-Care accusing Abbott of reporting inflated prices for generic drugs containing the antibiotic erythromycin to Medicaid.

In motions filed Friday in the U.S. District Court for the District of Massachusetts, Ven-A-Care and Abbott each asked for summary judgment on a number of different claims.

Ven-A-Care sought summary judgment that Abbott reported false drug prices, that these false prices caused overpayment by Medicaid, that Abbott's...
To view the full article, register now.